Cengild Medical Bhd (XKLS:0243) Growth Rank: 8 (As of Aug. 24, 2026) — 14% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XKLS:0243 Cengild Medical Bhd XKLS:0243
62 GF Score
Price RM0.20
GF Value RM0.29
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Cengild Medical Bhd Growth Rank?

Cengild Medical Bhd XKLS:0243 62 Growth Rank is 8 as of Aug. 24, 2026, which is 14% above its 10-year median of 7.00. GuruFocus rates XKLS:0243 with a GF Score™ of 62/100 and a GF Value™ of RM0.29 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Cengild Medical Bhd has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

Cengild Medical Bhd Growth Rank Related Terms

XKLS:0243 vs HCA, THC, DVA: Growth Rank Comparison

For the Medical Care Facilities subindustry, Cengild Medical Bhd's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cengild Medical Bhd Growth Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Cengild Medical Bhd's Growth Rank distribution charts can be found below:

* The bar in red indicates where Cengild Medical Bhd's Growth Rank falls into.


XKLS:0243
62GF Score
Cengild Medical Bhd XKLS:0243
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
Cengild Medical Bhd (XKLS:0243) has a Growth Rank of 8 as of Aug. 24, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Cengild Medical Bhd and its competitors. This is 14% above median its historical median of 7.00. Over the past decade, Cengild Medical Bhd's Growth Rank has ranged from 4.00 to 9.00.
Is Cengild Medical Bhd's Growth Rank too high?
Cengild Medical Bhd's current Growth Rank of 8 is 14% above median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 4.00 to a high of 9.00. Overall, Cengild Medical Bhd has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cengild Medical Bhd's Growth Rank compare to HCA and THC?
Cengild Medical Bhd's Growth Rank of 8 can be compared against companies in the Healthcare Providers & Services industry. Historically, Cengild Medical Bhd's own Growth Rank has ranged from 4.00 to 9.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Healthcare Providers & Services company?
A good Growth Rank depends on the Healthcare Providers & Services industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Cengild Medical Bhd and its competitors. Cengild Medical Bhd's current Growth Rank is 8, which is 14% above median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cengild Medical Bhd stock overvalued right now?
Based on GuruFocus' analysis, Cengild Medical Bhd (XKLS:0243) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.29, compared to a current price of RM0.20 — trading 32.8% below its estimated fair value. The current Growth Rank is 8, which is 14% above median its 10-year median of 7.00. Cengild Medical Bhd's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Cengild Medical Bhd (XKLS:0243), the current Growth Rank is 8 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cengild Medical Bhd (XKLS:0243) Overvalued in 2026?

Based on GuruFocus' analysis, Cengild Medical Bhd stock appears to be undervalued. The current stock price of RM0.20 is trading 32.8% below its estimated GF Value™ of RM0.29. GuruFocus considers Cengild Medical Bhd to be Significantly Undervalued.

Key valuation signals for XKLS:0243:

  • Growth Rank: 8 (14% above median its 10-year median of 7.00)
  • GF Value™: RM0.29 vs. price of RM0.20 (32.8% below fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the XKLS:0243 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cengild Medical Bhd Business Description

Address No.7, Jalan Kerinchi, Unit 2-3 & 2-4, Level 2, Nexus, Bangsar South, Kuala Lumpur, MYS, 59200
Cengild Medical Bhd is a healthcare service provider operating a medical centre specializing in the diagnosis and treatment of gastrointestinal-related diseases, oncology, gynecology services., liver diseases, and obesity. The company operates in Malaysia and has two reportable segments, Consultant Services and Medical Management Services. A substantial portion of the overall revenue is generated from its Medical Management Services segment.
62GF Score

Get the complete analysis for XKLS:0243

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.20
Price
RM0.29
GF Value